Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease

J Hepatol. 2015 Sep;63(3):763-5. doi: 10.1016/j.jhep.2015.06.004. Epub 2015 Jun 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antiviral Agents / administration & dosage*
  • Drug Therapy, Combination
  • Female
  • Hepatitis C / drug therapy*
  • Humans
  • Kidney Failure, Chronic / metabolism*
  • Male
  • Middle Aged
  • Simeprevir / administration & dosage*
  • Simeprevir / pharmacokinetics
  • Sofosbuvir / administration & dosage*
  • Sofosbuvir / pharmacokinetics

Substances

  • Antiviral Agents
  • Simeprevir
  • Sofosbuvir